Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasm Metastasis × pixantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, Non-Hodgkin 2 Recurrence 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

pembrolizumab 49 Gemcitabine 33 Biopsy 32 Specimen Handling 31 Magnetic Resonance Spectroscopy 30 Nivolumab 28 Paclitaxel 26 Irinotecan 23 Cyclophosphamide 21 Cisplatin 21 Bevacizumab 21 Fluorouracil 20 Carboplatin 19 Docetaxel 18 Oxaliplatin 17 Leucovorin 17 Cetuximab 16 130-nm albumin-bound paclitaxel 15 Capecitabine 14 Ipilimumab 13 Everolimus 13 Albumin-Bound Paclitaxel 13 Trastuzumab 12 Erlotinib Hydrochloride 12 olaparib 11 Sorafenib 11 trastuzumab deruxtecan 10 durvalumab 10 Radiosurgery 10 Pemetrexed 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01632436 2023-10-02

Hepatic

CTI BioPharma

Phase 1 Withdrawn

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡